We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+0.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.8B
AUM Growth
+$101M
(+0.45%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,075
New
272
Increased
822
Reduced
479
Closed
218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$58.5M |
| 2 |
Constellation Brands
STZ
|
+$45.5M |
| 3 |
Aptiv
APTV
|
+$45.5M |
| 4 |
NBL
Noble Energy, Inc.
NBL
|
+$44.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$85M |
| 2 |
American Airlines Group
AAL
|
+$47.2M |
| 3 |
AES
AES
|
+$47M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$38.2M |
| 5 |
Edison International
EIX
|
+$37.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.12% |
| 2 | Healthcare | 14.68% |
| 3 | Technology | 14.21% |
| 4 | Industrials | 9.59% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.81T
| $711M | 3.12% |
22,687,892
-695,668
| -3% | -$22.3M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $318M | 1.4% |
1,049,373
-16,488
| -2% | -$4.92M |
|
3
Microsoft
MSFT
$2.95T
| $314M | 1.38% |
7,112,831
-178,745
| -2% | -$8.16M |
|
4
Alphabet (Google) Class C
GOOG
$4.22T
| $291M | 1.28% |
10,972,160
+306,979
| +3% | +$8.22M |
|
5
ExxonMobil
XOM
$629B
| $289M | 1.27% |
3,471,029
-19,809
| -0.6% | -$1.7M |
|
6
GE Aerospace
GE
$354B
| $245M | 1.08% |
1,926,598
+101,602
| +6% | +$13.2M |
|
7
Procter & Gamble
PG
$345B
| $240M | 1.06% |
3,072,968
+99,728
| +3% | +$8.02M |
|
8
JPMorgan Chase
JPM
$901B
| $235M | 1.03% |
3,469,598
-173,582
| -5% | -$11.3M |
|
9
Wells Fargo
WFC
$261B
| $232M | 1.02% |
4,124,880
-70,360
| -2% | -$3.92M |
|
10
Citigroup
C
$216B
| $217M | 0.95% |
3,928,370
-103,191
| -3% | -$5.61M |
|
11
Chevron
CVX
$381B
| $212M | 0.93% |
2,201,276
+192,362
| +10% | +$20.2M |
|
12
Johnson & Johnson
JNJ
$599B
| $207M | 0.91% |
2,119,146
-40,825
| -2% | -$4.09M |
|
13
Verizon
VZ
$182B
| $195M | 0.86% |
4,186,935
-454,232
| -10% | -$22.2M |
|
14
Coca-Cola
KO
$353B
| $190M | 0.83% |
4,840,997
+328,546
| +7% | +$13.4M |
|
15
Gilead Sciences
GILD
$165B
| $178M | 0.78% |
1,520,966
-166,086
| -10% | -$18.1M |
|
16
Berkshire Hathaway Class B
BRK.B
$1.06T
| $177M | 0.78% |
1,302,601
+19,186
| +1% | +$2.74M |
|
17
Amazon
AMZN
$2.66T
| $172M | 0.75% |
7,903,880
+55,580
| +0.7% | +$1.16M |
|
18
Bank of America
BAC
$430B
| $171M | 0.75% |
10,056,491
-19,648
| -0.2% | -$324K |
|
19
Visa
V
$677B
| $169M | 0.74% |
2,515,031
-30,549
| -1% | -$2.07M |
|
20
Walt Disney
DIS
$167B
| $169M | 0.74% |
1,479,393
-21,130
| -1% | -$2.32M |
|
21
AT&T
T
$155B
| $167M | 0.73% |
6,223,571
+843,281
| +16% | +$21.8M |
|
22
IBM
IBM
$198B
| $166M | 0.73% |
1,068,956
-74,205
| -6% | -$11.9M |
|
23
CVS Health
CVS
$137B
| $157M | 0.69% |
1,499,503
+136,080
| +10% | +$13.9M |
|
24
Medtronic
MDT
$107B
| $157M | 0.69% |
2,119,637
-87,021
| -4% | -$6.65M |
|
|
25
Meta Platforms (Facebook)
META
$1.63T
| $154M | 0.68% |
1,800,959
+532,128
| +42% | +$43.5M |
|
Similar funds
RG
KK
VAI
STRS Ohio's Q2 2015 Portfolio in Review
As of Q2 2015, STRS Ohio held 2,075 positions worth $22.8B, up 0.45% from $22.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio's Q2 2015 filing shows 272 new, 822 increased, 479 reduced and 218 closed positions. Its largest new stake was Ingredion: 315,000 shares worth $25.1M. The largest sale was Boston Scientific, an estimated $85M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- STRS Ohio's largest Q2 2015 buy was Ingredion: 315,000 shares worth $25.1M.
- STRS Ohio added most to MALLINCKRODT PUBLIC LIMITED COMPANY in Q2 2015, an estimated $58.5M increase.
- STRS Ohio's biggest Q2 2015 reduction was Boston Scientific, cutting an estimated $85M.
- STRS Ohio fully exited Ryder in Q2 2015, selling an estimated $29.3M.
- STRS Ohio's ten largest holdings make up 14% of its $22.8B portfolio in Q2 2015.
- STRS Ohio opened 272 new positions and closed 218 in Q2 2015.
- STRS Ohio's portfolio value rose 0.45% quarter-over-quarter to $22.8B.
Based on STRS Ohio's 13F filing for Q2 2015, filed 4 Aug 2015.